Infection Prevention Pipeline Innovation

A multinational medical technology company was seeking to expand its portfolio of infection prevention products and services in Europe. SGV identified the ideal investment opportunities and engaged clinical experts to develop new concepts that could be added to the pipeline. We then conducted multiple phases of research to validate the ideal portfolio of products for individual markets.

• Opportunity Mapping

• Concept Development & Validation

• Portfolio Planning & Pricing